USPTO serial 79208547
IMOTOPE
Reviewed by CopyMark Law Group
Reg. 5348342Status 709
- Filing date
- Status date
- Registration date
- Dec 5, 2017
- Examiner
- LEIPZIG, MARC J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with IMOTOPE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
B-4000 Liège, BE
B-4000 Liège, BE
B-4000 Liège, BE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Martin W. Schiffmiller
Martin W. Schiffmiller Kirschstein Israel Schiffmiller & Pieroni, P.C.425 Fifth Avenue, 5th Floor, Suite 501New York, NY 10016-2223UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for use in the treatment and prevention of autoimmune diseases, infectious diseases, cancer, multiple sclerosis, type 1 diabetes, myasthenia gravis, rheumatoid arthritis and viral diseases, allergies, celiac disease and immune responses against allofactors used for therapy, viral vectors used for gene therapy or gene vaccination and autoimmune responses to organ or cellular transplantation; veterinary preparations for mammals for use in the treatment and prevention of autoimmune diseases, infectious diseases and cancer; vaccines; vaccine preparations for human or veterinary use | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services, namely, scientific research, analysis and design in the fields of immunology, chronic diseases, infectious diseases, cancer and regeneration of damaged organs; industrial research and analysis in the fields of immunology, chronic diseases, infectious diseases, cancer and regeneration of damaged organs; research and development of vaccines and medicines | SECTION 71 - CANCELLED | — |
| 044 | Medical services; veterinary services; hygienic and beauty care for human beings and animals; providing medical information concerning vaccination | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 5, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 30, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 19, 2025 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 29, 2025 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Mar 29, 2025 | INPC | INVALIDATION PROCESSED | — |
| Feb 21, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 21, 2024 | C71T | CANCELLED SECTION 71 | — |
| Dec 5, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 12, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 20, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 20, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 5, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 5, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 19, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 19, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 30, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 14, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 14, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 14, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 14, 2017 | ALIE | ASSIGNED TO LIE | — |
| Jul 20, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 20, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 20, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 1, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 15, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 14, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 6, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 2, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 1, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 31, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| May 31, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 25, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |